Study of HIV-immune patients yields path to antibody precursors

07/19/2013 | InfectionControlToday.com

A Scripps Research Institute-led team studied antibodies from the blood of people whose immune systems can find and neutralize HIV. Scientists reverse-engineered molecules that triggered precursors to HIV-fighting antibodies and are hopeful that the technique could be useful in developing a vaccine. "What we tried to do was to learn how those antibodies developed over the course of natural infection and attempt to guide the immune response in the direction of what we know works in certain HIV-infected individuals," biologist Jean-Philippe Julien said.

View Full Article in:

InfectionControlToday.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI